Cargando…

Variable frequency stimulation of sacral neuromodulation in black-zone overactive bladder patients: a case report

Overactive bladder (OAB) is a common urological disease, reducing patient quality of life (QoL). Sacral neuromodulation (SNM) is a treatment option used when conservative treatment is inadequate. However, constant frequency stimulation-SNM (CFS-SNM) may not be sufficiently effective in achieving tar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Lingfeng, Diao, Tongxiang, Wang, Miao, Liu, Xiaodong, Zhang, Wei, Tian, Zijian, Wang, Jianye, Zhang, Yaoguang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807324/ https://www.ncbi.nlm.nih.gov/pubmed/33457256 http://dx.doi.org/10.21037/tau-20-889

Ejemplares similares

Variable- versus constant-frequency sacral neuromodulation in black-zone overactive bladder patients: a study protocol for a multicenter, prospective, randomized, blind, self-controlled trial
por: Meng, Lingfeng, et al.
Publicado: (2021)

Sacral neuromodulation for overactive bladder using the InterStim and BetterStim systems
por: Meng, Lingfeng, et al.
Publicado: (2022)

Intermediate-term results of a prospective, multicenter study on remote programming sacral neuromodulation for refractory overactive bladder
por: Zhang, Yaoguang, et al.
Publicado: (2021)

Effects of Acute Sacral Neuromodulation at Different Frequencies on Bladder Overactivity in Pigs
por: Li, Xing, et al.
Publicado: (2017)

Sacral neuromodulation in overactive bladder: a review and current perspectives
por: Sukhu, Troy, et al.
Publicado: (2016)

Effects of Acute Sacral Neuromodulation at Different Pulse Widths on Bladder Overactivity in Pigs
por: Cong, Huiling, et al.
Publicado: (2019)

Outcomes of Intradetrusor Onabotulinum Toxin A Therapy in Overactive Bladder Refractory to Sacral Neuromodulation
por: Trinh, Hamilton, et al.
Publicado: (2019)

Sleep disturbance changes in women after treatment of refractory overactive bladder with sacral neuromodulation
por: Sanderson, Derrick J., et al.
Publicado: (2020)

Do Failure of Posterior Tibial Nerve Stimulation Precludes to Use Sacral Neuromodulation in Patient With Overactive Bladder?
por: Berthelot, Louis-Paul, et al.
Publicado: (2019)

Axonics Sacral Neuromodulation System for Treating Refractory Overactive Bladder: A NICE Medical Technologies Guidance
por: Poole, Ruth Louise, et al.
Publicado: (2021)

DNA methylation-based classification and identification of bladder cancer prognosis-associated subgroups
por: Tian, Zijian, et al.
Publicado: (2020)

Acute effect of sacral neuromodulation for treatment of detrusor overactivity on urodynamic parameters
por: Groenendijk, Ilse M., et al.
Publicado: (2019)

Young age increases the risk of lymph-node metastasis in patients with muscle-invasive bladder urothelial carcinoma
por: Tian, Zijian, et al.
Publicado: (2020)

Caspase 4 Overexpression as a Prognostic Marker in Clear Cell Renal Cell Carcinoma: A Study Based on the Cancer Genome Atlas Data Mining
por: Meng, Lingfeng, et al.
Publicado: (2021)

Using electroacupuncture with optimized acupoint positioning to predict the efficacy of sacral neuromodulation of refractory overactive bladder: A case report
por: Shen, Jianwu, et al.
Publicado: (2019)

Medium-term outcomes of sacral neuromodulation in patients with refractory overactive bladder: A retrospective single-institution study
por: Kaaki, Bilal, et al.
Publicado: (2020)

A comparative study between sacral neuromodulation and intravesical botulinum toxin injection for patients with refractory overactive bladder
por: Al-Azzawi, Issam S., et al.
Publicado: (2020)

Two‐year safety and efficacy outcomes for the treatment of overactive bladder using a long‐lived rechargeable sacral neuromodulation system
por: Blok, Bertil, et al.
Publicado: (2020)

Sacral Neuromodulation for Bladder Atony – A Case Report()
por: Sujka, Joseph, et al.
Publicado: (2014)

Pelvic Electrical Neuromodulation for the Treatment of Overactive Bladder Symptoms
por: Al-Shaiji, Tariq F., et al.
Publicado: (2011)

Predictive Nomogram and Risk Factors for Lymph Node Metastasis in Bladder Cancer
por: Tian, Zijian, et al.
Publicado: (2021)

Sacral neuromodulation in patients with refractory overactive bladder symptoms after failed Botulinum toxin therapy: Results in a large cohort of patients
por: Reekmans, Mathias, et al.
Publicado: (2021)

Refractory overactive bladder patients who chose sacral neuromodulation therapy after failed OnabotulinumtoxinA treatment: A systematic review and meta-analysis
por: Yang, Guang, et al.
Publicado: (2020)

Noninvasive spinal neuromodulation mitigates symptoms of idiopathic overactive bladder
por: Zhong, Hui, et al.
Publicado: (2022)

CGN Correlates With the Prognosis and Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma
por: Tian, Zijian, et al.
Publicado: (2022)

Is Sacral Neuromodulation a Treatment Option for Primary Bladder Neck Obstruction?
por: Alzahrani, Ibrahim, et al.
Publicado: (2022)

Treatment for overactive bladder: A meta-analysis of tibial versus parasacral neuromodulation
por: Wang, Zhi-Hong, et al.
Publicado: (2022)

Sacral neuromodulation in sphincteric disorders
por: Lavano, A
Publicado: (2010)

Sacral neuromodulation: Therapy evolution
por: Thompson, Jannah H., et al.
Publicado: (2010)

Sacral neuromodulation - when and for who
por: Mass-Lindenbaum, Marcelo, et al.
Publicado: (2021)

Expanding the Role of Neuromodulation for Overactive Bladder: New Indications and Alternatives to Delivery
por: Le, Ngoc-Bich, et al.
Publicado: (2010)

Construction and External Validation of a Ferroptosis-Related Gene Signature of Predictive Value for the Overall Survival in Bladder Cancer
por: Liu, Jingchao, et al.
Publicado: (2021)

Sacral neuromodulation remote programming in patients with refractory lower urinary tract dysfunction: China’s experience during the COVID-19 pandemic
por: Meng, Lingfeng, et al.
Publicado: (2023)

Feasibility of Real-Time Conditional Sacral Neuromodulation Using Wireless Bladder Pressure Sensor
por: Majerus, Steve J.A., et al.
Publicado: (2021)

Nomograms to predict individual prognosis of patients with primary signet ring cell carcinoma of the urinary bladder
por: Ma, Tianming, et al.
Publicado: (2021)

A comparison of sacral neuromodulation vs. transvaginal electrical stimulation for the treatment of refractory overactive bladder: the impact on quality of life, body image, sexual function, and emotional well-being
por: La Rosa, Valentina Lucia, et al.
Publicado: (2019)

Sacral Neuromodulation for Refractory Bladder Pain Syndrome/Interstitial Cystitis: a Global Systematic Review and Meta-analysis
por: Wang, Junpeng, et al.
Publicado: (2017)

Neuromodulation – a therapeutic option for refractory overactive bladder. A recent literature review
por: Szymański, Jacek K., et al.
Publicado: (2019)

Transcutaneous Electrical Spinal Cord Neuromodulator (TESCoN) Improves Symptoms of Overactive Bladder
por: Kreydin, Evgeniy, et al.
Publicado: (2020)

Patient‐tailored healthcare and tibial nerve neuromodulation in the treatment of patients with overactive bladder symptoms
por: te Dorsthorst, Manon, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k21efdkhkk3oga2to1avnik49i